ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2026
Time-Dependent Efficacy of Lymphaticovenous Anastomosis in Secondary Lymphedema: A Rabbit Model Study.
Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Secondary lymphedema remains a common complication after oncologic lymph node dissection. The optimal timing of lymphaticovenous anastomosis (LVA) is unclear due to a lack of time-dependent large-animal models. Twenty-five New Zealand White rabbits underwent popliteal-region surgery to induce secondary hind limb lymphedema. Animals received immediate LVA (n = 5) or delayed LVA at 4, 8, or 12 weeks after model induction (n = 5 per group); untreated lymphedema controls were included (n = 5). Outcomes included limb circumference/swelling rate, anastomotic patency by indocyanine green (ICG) fluorescence imaging, and histopathology/molecular markers (e.g., VEGF-C, LYVE-1). The model produced sustained hind limb swelling and molecular evidence of lymphangiogenic remodeling (e.g., increased VEGF-C and LYVE-1). Immediate LVA achieved 100% technical success with durable patency during follow-up. Delayed LVA groups demonstrated patency rates of approximately 75%-80%. Immediate intervention resulted in the greatest long-term reduction in swelling compared with delayed interventions. Mean lymphatic and venous diameters were approximately 0.6 and 0.8 mm, respectively, and mean operative time was ~55 min. This rabbit model provides a reproducible platform to evaluate time-dependent LVA efficacy. Earlier intervention yielded superior functional outcomes, while delayed LVA remained feasible and maintained reasonable patency, supporting a clinically relevant therapeutic window.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.